Abstract:
The present invention describes a method for germination activating spores of red Ganoderma lucidum to produce bioactive substances which has medicinal effects on patients with immunological disorders, cancer, AIDS, hepatitis, diabetes, and cardiovascular diseases, and can prevent or inhibit free radical oxidation and hepatotoxic effects. The method can be subdivided into three stages. At the first stage, a germination activation method is introduced which includes soaking the spores in a solution to induce germination, and placing the germination treated spores in a culture box to induce the synthesis of bioactive substances and softening of the cell walls of the spores. At the second stage, sporoderm-broken ganoderma spores are collected by treating the epispores with cell wall breaking enzymes and/or mechanical force. At the last stage, the bioactive substances are extracted from the sporoderm-broken spores by drying at low temperature followed by extraction.
Abstract:
Systems, methods, and computer-readable storage media for providing query-completion suggestions configured to be searched against vertical information domains in response to receiving a general web search query are provided. At least a portion of a general web search query is received. As the portion of the general web search query is received, query-completion suggestions are determined as is a likely primary intent associated with at least a portion of the determined query-completion suggestions. If the likely primary intent associated with a particular query-completion suggestion is for information associated with a particular vertical information domain other than the general web domain, the query-completion suggestion is provided such that selection thereof causes searching of the query-completion suggestion against the particular information domain for search results.
Abstract:
Lanosterol derivatives useful as anti-cancer agent, which can inhibit the growth of lung cancer cells, liver cancer cells, mammary cancer cells, brain cancer cells and pancreatic cancer cells, possibly by acting on the RHO pathway. These lanosterol derivatives are represented by compound LD030:
Abstract:
The present invention relates to the field of pharmaceutical chemistry, and in particular, to a benzopyrone derivative and a use thereof. The benzopyrone derivative is compound having a structure of formula (I) or a pharmaceutically acceptable salt thereof. It has been found by experiments that, this type of compounds is useful in prevention or treatment of neuropsychical diseases.
Abstract:
A method is provided for receiving a differential signal pair input at a first circuit stage and converting the differential signal pair input to a single-ended signal at a second circuit stage. The method also provides for receiving an output of the first circuit stage and an output of the second stage at a third circuit stage and transmitting an amplified signal output from the third circuit stage. The method allows for a 60 dB signal gain or more. A circuit is also provided that includes multiple circuit stages that can provide signal gain to an input differential signal pair. The circuit converts the differential pair into a single-ended signal and transmits the amplified signal as an output. The circuit provides the signal gain without using a current mirror. A computer readable storage device encoded with data for adapting a manufacturing facility to create an apparatus is also provided.
Abstract:
A process and system for feeding solids and carrier gases through the wall of a duct or chamber through which a gas stream flows to the flowing gas stream from a feed source exterior of the duct or chamber.
Abstract:
An ablation planning system includes a user interface (104) configured to permit selection of inputs for planning an ablation procedure. The user interface is further configured to incorporate selection of ablation probes and one or more combinations of ablation powers, durations or parameters applicable to selected probes in the inputs to size the ablation volumes. The user interface includes a display for rendering internal images of a patient, the display permitting visualizations of the ablation volumes for different entry points on the internal images. An optimization engine (106) is coupled to the user interface to receive the inputs and is configured to output an optimized therapy plan which includes spatial ablation locations and temporal information for ablation so that collateral damage is reduced, coverage area is maximized and critical structures are avoided in a planned target volume.
Abstract:
An electrocardiogram signal processing system is provided which includes: a wavelet transformation unit comprising a plurality of outputs, each output being connected to one of a plurality of scales, wherein the wavelet transformation unit is adapted to transform an input electrocardiogram signal into a set of wavelets, each wavelet being output to one of the scales; a plurality of signal processing blocks, each of the signal processing blocks coupled to a respective output of the wavelet transformation unit and configured to receive and process the wavelet from the respective output, wherein the signal processing blocks provide processing functions which differ from one another.
Abstract:
This invention relates to a cationically and amphiphilically modified polygalactomannan having repeating units with an average D-mannosyl to D-galactosyl residue ratio of at least 5 to 1 and to compositions containing same. A portion of the hydrogen atoms of hydroxyl groups situated on the mannosyl and galactosyl residues of the galactomannan are replaced with an amphiphilic and a cationic substituent.
Abstract:
In one embodiment, a request is generated for a particular device of a computer network for a unique segment identifier (ID) for a network segment comprising one or more devices sharing a unique tenant ID. The request has a request-context that includes the tenant ID and a protocol of the network segment. The request is transmitted a segment ID manager and, as a result, the segment ID manager generates and transmits a response that indicates the unique segment ID for the network segment based on the request-context. Subsequently, the particular device may then be configured to communicate on the network segment with the one or more devices based on the unique segment ID of the response.